Sei Investments CO Harrow Health, Inc. Transaction History

Sei Investments CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$22.22 - $36.67 $295,237 - $487,234	-13,287 Reduced 52.85%	11,853 $315,000
Q1 2025 May 13, 2025	SELL	$22.22 - $36.67 $1,466 - $2,420	-66 Reduced 0.26%	25,140 $668,000
Q4 2024 Feb 11, 2025	BUY	$33.39 - $57.5 $318,106 - $547,802	9,527 Added 60.76%	25,206 $845,000
Q3 2024 Nov 12, 2024	BUY	$20.85 - $46.47 $326,907 - $728,603	15,679 New	15,679 $704,000
Q1 2023 May 12, 2023	BUY	$13.84 - $21.46 $310,099 - $480,832	22,406 New	22,406 $474,000

219

21.7M

998K

593K

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $1.1B
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.